Resistance to drugs is a clinical problem. Downregulating the gene RPN2, which encodes part of an N-oligosaccharyl transferase complex, sensitized breast cancer cells to the cancer drug docetaxel in vivo and in vitro. RPN2 might be a therapeutic target against drug resistance in cancer.
- Kimi Honma
- Kyoko Iwao-Koizumi
- Takahiro Ochiya